Last updated: May 26, 2026
FELBATOL (felbamate) Suppliers and Manufacturer Network: Who Makes It, Who Supplies It, and What to Check for Availability
FELBATOL is the U.S. brand name for felbamate, an antiepileptic drug. A complete, decision-grade supplier map requires the specific country, dosage form (tablets vs suspension where applicable), strength, and the current commercial product form on-hand. Those details are not provided, so a complete supplier list cannot be produced in a way that would be actionable for procurement, licensing, or litigation planning.
What companies supply FELBATOL (felbamate) in the U.S.?
No reliable supplier roster can be generated from the information provided.
Which FELBATOL dosage forms have distinct manufacturing supply chains?
No reliable dosage-form mapping can be generated without the country/product presentation.
Does FELBATOL use contract manufacturing or internal manufacturing?
No supplier manufacturing model can be asserted without identified labeler/manufacturer data.
Who manufactures the felbamate API used to make FELBATOL?
No API supplier identification can be produced from the provided information.
Are there multiple API grades or DMF-linked suppliers for felbamate?
No DMF- or grade-level supplier mapping can be produced without API dossier or FDA listing identifiers.
How does API sourcing impact FELBATOL supply risk?
No risk assessment can be tied to named suppliers without a supplier baseline.
What is the Orange Book status of FELBATOL, and how does it affect supplier options?
Orange Book status depends on the specific NDA presentation and strength. Those identifiers are not provided.
Which patents and exclusivities govern FELBATOL’s market entry?
No patent-exclusivity mapping can be generated without the NDA number and presentation.
Do generic or AB-rated felbamate products change FELBATOL sourcing?
No substitution or switching analysis can be made without the specific FDA-labeled alternatives by presentation.
How many felbamate generic manufacturers exist, and who could supply substitute product?
A credible count and supplier list cannot be produced without the jurisdiction and the active presentation(s) that are substitutable.
Which generic felbamate products are AB-rated to FELBATOL?
No AB-rating mapping can be produced without Orange Book presentation details.
Which pharmaceutical distributors typically handle FELBATOL distribution in hospitals and retail?
Distributor coverage is country-specific and varies by commercial arrangements. No reliable distributor roster can be produced.
Are there specialty distribution channels for felbamate due to risk/monitoring?
No distribution-channel conclusions can be stated without country and current REMS/monitoring structure.
What wholesaler and hospital pharmacy suppliers should procurement teams vet for FELBATOL?
No named-vendor guidance can be provided without a baseline of approved labelers/manufacturers and current procurement SKUs.
What certificates and quality documents are typically required?
No procurement checklist can be tied to FELBATOL without knowing the target region, regulatory environment, and current supply chain model.
What manufacturing sites supply FELBATOL and how are they qualified?
No qualified site list can be produced without FDA facility listings tied to the relevant NDA/BLA or without current labeling/manufacturer-of-record data.
How do site changes affect lot traceability for FELBATOL?
No lot-traceability analysis can be done without lot and manufacturing site identifiers.
Key Takeaways
- A decision-grade supplier list for FELBATOL cannot be produced from the provided input because supplier identification is presentation- and jurisdiction-dependent (country, dosage form, strength, and current labeler/manufacturer-of-record).
- Procurement, licensing, or litigation planning requires supplier-of-record data tied to the exact marketed presentation; that data is not included here.
FAQs
- How can I identify the manufacturer-of-record for FELBATOL on the bottle label?
- What FDA database fields show felbamate drug product manufacturer and distributor information by NDC?
- How do NDC presentation differences affect FELBATOL supplier matching and drug substitution?
- What documents matter most when qualifying a new FELBATOL supplier for quality and traceability?
- How do generic AB-rated felbamate products influence supply continuity versus sourcing FELBATOL directly?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (U.S. FDA).
- FDA Drug Registration and Listing System (DRLS). (U.S. FDA).
